Prognostic Impact of Immunoscore in Pathological Stage <scp>III</scp> Differentiated Gastric Cancer: A Multicenter Cohort Study Including <scp>PD</scp> ‐ <scp>L1</scp> / <scp>PD</scp> ‐ <scp>L2</scp> Expression Analysis
Histological classification may be useful in assessing the tumor microenvironment in GC, and patients with differentiated-type pStage III with a low IS signature may be candidates for more intensive perioperative treatment due to their higher risk of recurrence.
Authors
- Yusuke Akamaru
- Yuichiro Doki
- Kazuyoshi Yamamoto (ORCID: https://orcid.org/0000-0002-7645-2412)
- Yukinori Kurokawa (ORCID: https://orcid.org/0000-0002-2883-0132)
- Takahiro Matsui (ORCID: https://orcid.org/0000-0002-6753-1688)
- Eiichi Morii (ORCID: https://orcid.org/0000-0001-8490-3650)
- Kazumasa Fujitani (ORCID: https://orcid.org/0000-0003-4954-5047)
- Yoshiro Yukawa
- Takuro Saito (ORCID: https://orcid.org/0000-0002-1733-5064)
- Hidetoshi Eguchi (ORCID: https://orcid.org/0000-0002-2318-1129)
- Jin Matsuyama (ORCID: https://orcid.org/0000-0001-9060-282X)
- Shinya Kidogami
- Tsuyoshi Takahashi (ORCID: https://orcid.org/0000-0003-2397-1478)
- Hiroshi Imamura (ORCID: https://orcid.org/0000-0002-4294-6289)
Institutions
- Osaka Prefectural Medical Center (JP)
- Toyonaka Municipal Hospital (JP)
- Osaka City General Hospital (JP)
- Saiseikaisenri Hospital (JP)
- Osaka Rosai Hospital (JP)
- Higashi Osaka City General Hospital (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Annals of Gastroenterological Surgery
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1002/ags3.70114
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00